arrow
S

Satoshi Tanaka

osaka national hospital
H指数:20
被引数:1,735

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Effect of sofosbuvir and velpatasvir therapy on clinical outcome in hepatitis C virus patients with decompensated cirrhosis

sofosbuvir和velpatasvir治疗对丙型肝炎病毒肝硬化失代偿期患者临床结局的影响

2022-12-226
PRE
Persistent hepatocyte apoptosis promotes tumorigenesis from diethylnitrosamine-transformed hepatocytes through increased oxidative stress, independent of compensatory liver regeneration

持续的肝细胞凋亡通过增加氧化应激促进二乙基亚硝胺转化的肝细胞的肿瘤发生,而与代偿性肝再生无关

2021-02-096
OAAI
Hepatitis C virus enhances Rubicon expression, leading to autophagy inhibition and intracellular innate immune activation

丙型肝炎病毒增强Rubicon表达,导致自噬抑制和细胞内固有免疫激活

2020-09-1719
OAAI
DNase II activated by the mitochondrial apoptotic pathway regulates RIP1-dependent non-apoptotic hepatocyte death via the TLR9/IFN-β signaling pathway

线粒体凋亡途径激活的DNase II通过TLR9/ifn-β 信号通路调节RIP1-dependent非凋亡性肝细胞死亡

2018-05-3148
OAAI
Rubicon Inhibits Autophagy and Accelerates Hepatocyte Apoptosis and Lipid Accumulation in Nonalcoholic Fatty Liver Disease in Mice

Rubicon抑制非酒精性脂肪性肝病小鼠自噬并促进肝细胞凋亡和脂质积累

2016-10-21281
PREAI
Sodium taurocholate cotransporting polypeptide inhibition efficiently blocks hepatitis B virus spread in mice with a humanized liver

牛磺胆酸钠共转运多肽抑制有效阻断乙型肝炎病毒在具有人源化肝脏的小鼠中的传播

2016-06-0922
OAAI
S100A8 Production in CXCR2-Expressing CD11b+Gr-1high Cells Aggravates Hepatitis in Mice Fed a High-Fat and High-Cholesterol Diet

CXCR2-Expressing CD11b Gr-1high细胞中S100A8的产生加重了高脂高胆固醇饮食小鼠的肝炎

2016-01-0128
PREAI
Emergence of hepatitis C virus NS5A L31V plus Y93H variant upon treatment failure of daclatasvir and asunaprevir is relatively resistant to ledipasvir and NS5B polymerase nucleotide inhibitor GS-558093 in human hepatocyte chimeric mice

daclatasvir和asunaprevir治疗失败后丙型肝炎病毒NS5A L31V加Y93H变体的出现对人肝细胞嵌合小鼠中的ledipasvir和NS5B聚合酶核苷酸抑制剂GS-558093相对耐药

2015-07-2525
PREAI
Synthetic lethal interaction of combined CD26 and Bcl-xL inhibition is a powerful anticancer therapy against hepatocellular carcinoma

联合CD26和bcl-xl抑制的合成致死相互作用是针对肝细胞癌的强大抗癌疗法

2014-11-1212
PREAI